Navigation Links
Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
Date:11/6/2007

ORLANDO, Fla., Nov. 6 /PRNewswire-USNewswire/ -- The time it takes to treat heart attack patients can be reduced dramatically with a communication system that makes it possible for paramedics to send real-time medical information from the field to hospital emergency departments, according to a study from the Providence Hospital Heart Institute in Southfield, Mich. The study was presented today at the American Heart Association's 2007 Annual Scientific Sessions in Orlando.

The system, known as LIFENET, enables EMS units to transmit critical medical information to doctors while they are on the scene or transporting a patient to the hospital. Paramedics place a 12-lead electrocardiogram on the patient and the data from that ECG is transmitted to the emergency department via cell phone connection. Doctors can immediately determine if a patient is having a heart attack and prepare a cardiac catheterization lab where they can be treated with lifesaving balloon angioplasty to open any blocked arteries.

The Providence study, conducted from Oct. 2003 to May 2007, involved 142 consecutive patients that were in the midst of a heart attack. The conventional treatment group of 125 patients had an average door-to-balloon time of 123 minutes, while the 17 patients who had their ECG's transmitted from the field to the Emergency Department reached the catheterization lab for angioplasty in an average of 46 minutes. All of those patients had successful interventions and were released without complications.

"The use of this technology makes it possible for us to save more lives," says Shukri David, M.D., chief of cardiology at the Providence Hospital Heart Institute and the lead author of the study. "Patients are taken directly to the catheterization lab without the delays necessitated by emergency room admission and evaluation. The quicker we can re-open blocked arteries and re-establish blood flow to the heart, the better."

This study is a follo
'/>"/>

SOURCE St. John Health
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. Gilbert Hospital Continues Cutting Edge Treatments
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. Hospital to Hold MRSA Briefing for Media and Community Leaders
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...BEDFORD,Mass.,Nov.25/PRNewswire-FirstCall/--Hologi...gdeveloper,manufacturerandsupplierofpremiumdiagnos...atedtoservingthehealthcareneedsofwomen,isusingthea...(RSNA)atMcCormickPlaceinChicago,November29throughD...ultimodalitydiagnosticmammographyworkstationsoftwa...
(Date:11/25/2009)...EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGro...elara report,thefirstinamulti-phasesyndicatedmark...Biotech,sStelara,fromproductlaunchthroughthefirsts...quantitativeinformationfrom75uniqueDermatologistsa...assesstrialanduseofStelara,obstaclestouse,typicalp...
(Date:11/25/2009)...RANCHOCORDOVA,Calif.,Nov.25/PRNewswire/--AMPACFine...oration(Nasdaq: APFC )announcedtodaythatitreceived...rdattheAnnualStatewideEnvironmentalSummit,sponsore...ion(CMTA),theIndustrialEnvironmentalAssociation(IE...eldinSanDiego.Thisisthemostprestigiousawardavailab...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Mothers Immune System May Block Fetal Treatments for Blood Diseases 54639 1Mothers Immune System May Block Fetal Treatments for Blood Diseases 54639 2Mothers Immune System May Block Fetal Treatments for Blood Diseases 54639 3Mothers Immune System May Block Fetal Treatments for Blood Diseases 54639 4Gaiam Announces New Deal With Valerie Bertinelli 54637 1Gaiam Announces New Deal With Valerie Bertinelli 54637 2Chewing Tobacco No Safer Than Smoking 54635 1Chewing Tobacco No Safer Than Smoking 54635 2
...e-FirstCall/ -- Shire plc,announced today the posi...ication guanfacine extended release (GXR,previous...renoceptor agonist. These data from two short-term...-term phase III,open-label studies, presented at t...ual meeting, demonstrated that GXR,significantly i...
...tudies with Monoclonal Antibody,Targeting Interleu...ionale for IL-9 Inhibition in Developing Potential... /PRNewswire-FirstCall/ --,MedImmune, Inc. today a...ent progress within the company,s inflammatory,dis...clinical,studies with its monoclonal antibody (MAb...
Other Medicine Technology:Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7
(Date:11/25/2009)...dorsements,Business,andPressJoinEfforttoEducate ,...Onceagain,theNationalBipolarFoundationandtheMedicA...afe,tilStable"program,whichisnowbeingwidelyaccepte...Today,theNationalBipolarFoundationreceivedaproclam...mtheLt.GovernorofLouisianaMitchLandrieu.TheNationa...
(Date:11/25/2009)...ood pressure? This simple question has been the f...ss-related gene Modulates High Blood Pressure in M...This simple question has been the focus of intense...r the first time established a link between a nove... to stress in mice as well as humans. The studies ...
(Date:11/25/2009)...uld lead mothers to overlook needed care, study fi...ws) -- A mother,s depression can worsen her child,...six-month study of 262 black mothers and their chi...epressive symptoms had more frequent asthma sympto...e symptoms had less frequent asthma symptoms. ,...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--TheAmericanAssociation...tof2009,"S.2128,whichisdesignedtosubstantiallyimpr...are.ThebillwasintroducedbySen.GeorgeLeMieux(R-Fla....eAmericanAssociationforHomecareoutlinedinits13-poi...toCongressinFebruary.Thoseprovisionsincludecalling...
(Date:11/25/2009)...oblems that can occur in children with autism and ... plan that includes medication combined with a str... Yale University researchers and their colleagues.... Journal of the American Academy of Child and Adol... National Institute of Mental Health (NIMH) Resear...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Mom's Depression May Worsen Child's Asthma 2Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2
...ng poll series, Debating Health: Election 2008, th...arvard School of Public Health (HSPH) and Harris I...er voters believe the results of this presidential...oter cynicism in recent times, a majority of regis...
...received blood that was 29 days or older faced twi...y News) -- Hospital patients who receive a transfu... double the risk for developing one or more seriou...upper limit for blood storage at 42 days, at which...
... 28 Hillenbrand, Inc.,(NYSE: HI ) will host a co... 3, at the Millennium Broadway in New York City. S...e Kenneth A. Camp, Hillenbrand,president and chief... officer of Batesville Casket Company,Hillenbrand,...
... Counseling is one of the country’s fast...eed for doctoral degree programs and faculty to ed...als to oversee counselors. In response, Capella Un...s, has launched a new online PhD in Counselor Educ...
...ctober 28, 2008) Scientists at NanoBio Corporatio...hat a novel topical treatment for cold sores (herp... effectively as the leading oral systemic drugs bu...to oral systemic drugs, according to the NanoBio s...
... you know that one in six men will,be diagnosed wi...r occurs,every 2.5 minutes and a man dies from pro...n,s health first., Listen to this report from Phi...os for free and unrestricted use at http://www.me...
Other Medicine News:Health News:Majority of voters say election outcome will make a great deal of difference on key issues 2Health News:Majority of voters say election outcome will make a great deal of difference on key issues 3Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 2Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 3Health News: Capella University Launches PhD in Counselor Education and Supervision : The new degree program, one of few available online, addresses growing need for counseling faculty and supervisors 2Health News: Capella University Launches PhD in Counselor Education and Supervision : The new degree program, one of few available online, addresses growing need for counseling faculty and supervisors 3Health News:Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift 2
Illiterate 20' Test Chart
...ce recording unit suitable for a wide range of lif... 16 input channels. Examples include sleep, neurop... capable of recording at speeds of up to 200 000 s...patible with instruments, signal conditioners and ...
Three Figure Worth Type Test
Low Contrast Flip Chart with Lea Symbols
Medicine Products: